Advanced search
Start date
Betweenand
(Reference retrieved automatically from Web of Science through information on FAPESP grant and its corresponding number as mentioned in the publication by the authors.)

Prognostic Classifier Based on Genome-Wide DNA Methylation Profiling in Well-Differentiated Thyroid Tumors

Full text
Author(s):
dos Reis, Mariana Bisarro [1, 2, 3] ; Barros-Filho, Mateus Camargo [1, 2] ; Marchi, Fabio Albuquerque [1, 2] ; Beltrami, Caroline Moraes [1, 2] ; Kuasne, Hellen [1, 2] ; Lopes Pinto, Clovis Antonio [4] ; Ambatipudi, Srikant [5, 6] ; Herceg, Zdenko [5] ; Kowalski, Luiz Paulo [7] ; Rogatto, Silvia Regina [3, 8, 9]
Total Authors: 10
Affiliation:
[1] AC Camargo Canc Ctr, CIPE, Int Res Ctr, BR-01509010 Sao Paulo, SP - Brazil
[2] Natl Inst Sci & Technol Oncogen, BR-01509010 Sao Paulo, SP - Brazil
[3] Sao Paulo State Univ, Dept Urol, Fac Med, UNESP, BR-18618970 Botucatu, SP - Brazil
[4] AC Camargo Canc Ctr, Dept Pathol, BR-01509010 Sao Paulo, SP - Brazil
[5] IARC, Epigenet Grp, F-69372 Lyon - France
[6] Univ Bristol, Integrat Epidemiol Unit, MRC, Bristol BS8 1TH, Avon - England
[7] AC Camargo Canc Ctr, Dept Head & Neck Surg & Otorhinolaryngol, BR-01509010 Sao Paulo, SP - Brazil
[8] Univ Southern Denmark, Dept Clin Genet, Vejle Hosp, DK-7100 Vejle - Denmark
[9] Univ Southern Denmark, Inst Reg Hlth Res, Vejle Hosp, DK-7100 Vejle - Denmark
Total Affiliations: 9
Document type: Journal article
Source: JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM; v. 102, n. 11, p. 4089-4099, NOV 1 2017.
Web of Science Citations: 12
Abstract

Context: Even though the majority of well-differentiated thyroid carcinoma (WDTC) is indolent, a number of cases display an aggressive behavior. Cumulative evidence suggests that the deregulation of DNA methylation has the potential to point out molecular markers associated with worse prognosis. Objective: To identify a prognostic epigenetic signature in thyroid cancer. Design: Genome-wide DNA methylation assays (450k platform, Illumina) were performed in a cohort of 50 nonneoplastic thyroid tissues (NTs), 17 benign thyroid lesions (BTLs), and 74 thyroid carcinomas (60 papillary, 8 follicular, 2 Hurthle cell, 1 poorly differentiated, and 3 anaplastic). A prognostic classifier for WDTC was developed via diagonal linear discriminant analysis. The results were compared with The Cancer Genome Atlas (TCGA) database. Results: A specific epigenetic profile was detected according to each histological subtype. BTLs and follicular carcinomas showed a greater number of methylated CpG in comparison with NTs, whereas hypomethylation was predominant in papillary and undifferentiated carcinomas. A prognostic classifier based on 21 DNA methylation probes was able to predict poor outcome in patients with WDTC (sensitivity 63%, specificity 92% for internal data; sensitivity 64%, specificity 88% for TCGA data). High-risk score based on the classifier was considered an independent factor of poor outcome (Cox regression, P < 0.001). Conclusions: The methylation profile of thyroid lesions exhibited a specific signature according to the histological subtype. A meaningful algorithm composed of 21 probes was capable of predicting the recurrence in WDTC. (AU)

FAPESP's process: 15/20748-5 - Diagnostic and prognostic markers useful in the clinical practice for patients with thyroid nodules: validation of previous findings and functional studies
Grantee:Silvia Regina Rogatto
Support type: Regular Research Grants
FAPESP's process: 08/57887-9 - National Institute of Oncogenomics
Grantee:Luiz Paulo Kowalski
Support type: Research Projects - Thematic Grants